Kenvue Inc

NEW
HAM:J4D (USA)  
€ 17.36 +0.52 (+3.09%) Jul 7
23.27
P/B:
3.58
Market Cap:
€ 33.35B ($ 38.04B)
Enterprise V:
€ 40.13B ($ 45.78B)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Kenvue Inc
NAICS : 811490 SIC : 2842
ISIN : US49177J1025

Total Employee Number:

22,000
Description
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Financials (Next Earnings Date:2026-08-07 Est.)

HAM:J4D's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Kenvue Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 13,144.746
EPS (TTM) (€) 0.731
Beta 0.8519
3-Year Sharpe Ratio -0.32
3-Year Sortino Ratio -0.43
Volatility % 41.35
14-Day RSI 74.14
14-Day ATR (€) 0.240984
20-Day SMA (€) 16.2635
12-1 Month Momentum % -19.29
52-Week Range (€) 12.002 - 19.43
Shares Outstanding (Mil) 1,920.01

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kenvue Inc Filings

Filing Date Document Date Form
No Filing Data

Kenvue Inc Stock Events

Financials Calendars
Event Date Price (€)
Third quarter earnings conference call for 2026 2026-11-06 08:30 In 122 days
Third quarter earnings results for 2026 2026-11-06 In 121 days
Second quarter earnings conference call for 2026 2026-08-07 08:30 In 31 days
Second quarter earnings results for 2026 2026-08-07 In 30 days
General meeting for 2026 2026-05-21 09:00 14.84 (+1.40%)
USD 0.207500 Cash Dividend 2026-05-13 14.75 (+2.25%)
First quarter earnings results for 2026 2026-05-07 14.86 (+1.16%)
Annual report for 2025 2026-02-20 15.83 (-0.14%)
Fourth quarter earnings results for 2025 2026-02-17 15.57 (-0.06%)
USD 0.207500 Cash Dividend 2026-02-11 15.37 (+1.69%)
Show
Entries

Kenvue Inc Frequently Asked Questions

What is Kenvue Inc(HAM:J4D)'s stock price today?
The current price of HAM:J4D is €17.36. The 52 week high of HAM:J4D is €19.43 and 52 week low is €12.00.
When is next earnings date of Kenvue Inc(HAM:J4D)?
The next earnings date of Kenvue Inc(HAM:J4D) is 2026-08-07 Est..
Does Kenvue Inc(HAM:J4D) pay dividends? If so, how much?
The  Dividend Yield %  of Kenvue Inc(HAM:J4D) is 4.1% (As of Today), Highest Dividend Payout Ratio of Kenvue Inc(HAM:J4D) was 0.76. The lowest was 0.31. And the median was 0.71. The  Forward Dividend Yield % of Kenvue Inc(HAM:J4D) is 4.11%. For more information regarding to dividend, please check our Dividend Page.

Articles on Kenvue Inc

No articles.